NervGen Pharma Corp. , a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
Nervgen Pharma stock last closed at $1.78, up 1.14% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Nervgen Pharma stock is currently +12.66% from its 52-week low of $1.58, and -70.18% from its 52-week high of $5.97.
As of Oct 2, 2026, there are 106.41M NGEN shares outstanding. The market capitalization of NGEN is $189.41M. In the past 24 hours, 404,000 NGEN shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy NGEN shares.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, the next step is to fill out some personal information so you can invest in NGEN stock today.
Now that you've filled out your info on app for stock, you need to deposit funds:
Check out the walkthrough below if you need help transferring funds into your new investment account.
After you have chosen the best place to buy Nervgen Pharma stock, it's important to research their stock before you buy, so you can comprehend the risk as well as the opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on NGEN's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge NGEN's true value.
Using relative valuations measures:
You can do additional valuation analysis on NGEN's stock here.
Out of 2 Wall Street analysts who track NGEN, the consensus analyst rating on NGEN is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Nervgen Pharma stock forecast page.
In the past year, executives and large shareholders at NGEN have not bought or sold any shares.
Get more info about who owns NGEN stock here.
No, Nervgen Pharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two primary types of orders:
Hit the Open Trade button and eToro will place your order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some NGEN stock, you'll want to stay up-to-date on your company.
Create a watchlist to get the latest updates about your NGEN stock.
To reiterate, here are the 6 steps to buy Nervgen Pharma stock:
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Nervgen Pharma, add NGEN to your watchlist by clicking the button below.